Trade Mark Journal No.2026/004 23 January 2026

UK00004320900 8 January 2026 (5)

RUXREVO

Class 5
Pharmaceutical and medicinal preparations and substances; vaccines.

Glaxo Group Limited

Representative: Legal Brand Protection, GSK